Evidence map›Paper›PMID 37331957›Full record

ArticleBMC nephrology2023

Use of novel structural features to identify urinary biomarkers during acute kidney injury that predict progression to chronic kidney disease.

Jennifer R Charlton, Teng Li, Teresa Wu, Kimberly deRonde, Yanzhe Xu, Edwin J Baldelomar, Kevin M Bennett

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Assessment of Acute Kidney Injury using MRI.Journal of magnetic resonance imaging : JMRI · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jennifer R CharltonSchool of Medicine, Department of Pediatrics, Division Nephrology, University of Virginia, Box 800386, Charlottesville, VA, 22903, USA. jrc6n@virginia.edu.ORCID 0000-0002-2225-535X
Teng LiDepartment of Computer Science, School of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, USA.
Teresa WuDepartment of Industrial Engineering, School of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, USA.
Kimberly deRondeSchool of Medicine, Department of Pediatrics, Division Nephrology, University of Virginia, Box 800386, Charlottesville, VA, 22903, USA.
Yanzhe XuDepartment of Industrial Engineering, School of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, USA.
Edwin J BaldelomarWashington University in St. Louis, Mallinckrodt Institute of Radiology, St. Louis MO, USA.
Kevin M BennettWashington University in St. Louis, Mallinckrodt Institute of Radiology, St. Louis MO, USA.
Arizona State University · USUniversity of Virginia · USWashington University in St. Louis · US

Funding

Single-Cell Epigenomics, Transcriptomics, and Bioinformatics CoreP50DK096373 · NIDDK · UNIVERSITY OF VIRGINIA · PI ROBERTO Ariel GOMEZ · 2012 to 2026
$13.8M
Coordinating Unit for DiaCompU24DK115255 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2017 to 2020
$11.6M
94 TESLA MR SCANNER FOR MURINE IMAGING: IMAGINGS10RR019911 · NCRR · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BERR, STUART S · 2005 to 2005
$2.0M
Comprehensive MRI-based evaluation of human renal microstructureR01DK111861 · NIDDK · UNIVERSITY OF VIRGINIA · PI BENNETT, KEVIN M, CHARLTON, JENNIFER R · 2017 to 2020
$1.8M
Noninvasive MRI techniques to detect pathology in murine models of renal diseaseR01DK110622 · NIDDK · WASHINGTON UNIVERSITY · PI BENNETT, KEVIN M, CHARLTON, JENNIFER R · 2017 to 2019
$1.0M
NCRR NIH HHS S10 RR019911NIDDK NIH HHS P50 DK096373NIDDK NIH HHS R01 DK110622NIDDK NIH HHS R01 DK111861NIDDK NIH HHS U24 DK115255
6 · The paper itself

Abstract

backgroundA significant barrier to biomarker development in the field of acute kidney injury (AKI) is the use of kidney function to identify candidates. Progress in imaging technology makes it possible to detect early structural changes prior to a decline in kidney function. Early identification of those who will advance to chronic kidney disease (CKD) would allow for the initiation of interventions to halt progression. The goal of this study was to use a structural phenotype defined by magnetic resonance imaging and histology to advance biomarker discovery during the transition from AKI to CKD.

methodsUrine was collected and analyzed from adult C57Bl/6 male mice at four days and 12 weeks after folic acid-induced AKI. Mice were euthanized 12 weeks after AKI and structural metrics were obtained from cationic ferritin-enhanced-MRI (CFE-MRI) and histologic assessment. The fraction of proximal tubules, number of atubular glomeruli (ATG), and area of scarring were measured histologically. The correlation between the urinary biomarkers at the AKI or CKD and CFE-MRI derived features was determined, alone or in combination with the histologic features, using principal components.

resultsUsing principal components derived from structural features, twelve urinary proteins were identified at the time of AKI that predicted structural changes 12 weeks after injury. The raw and normalized urinary concentrations of IGFBP-3 and TNFRII strongly correlated to the structural findings from histology and CFE-MRI. Urinary fractalkine concentration at the time of CKD correlated with structural findings of CKD.

conclusionsWe have used structural features to identify several candidate urinary proteins that predict whole kidney pathologic features during the transition from AKI to CKD, including IGFBP-3, TNFRII, and fractalkine. In future work, these biomarkers must be corroborated in patient cohorts to determine their suitability to predict CKD after AKI.

Indexed as

Acute Kidney InjuryRenal Insufficiency, ChronicAnimalsBiomarkersChemokine CX3CL1Insulin-Like Growth Factor Binding Protein 3MaleMiceBiomarkersChemokine CX3CL1Insulin-Like Growth Factor Binding Protein 3BiomarkerCFE-MRIFolic acid nephropathyNephron number

Identifiers

PMID37331957
PMCPMC10278294
OpenAlexW4381157931

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.